Testing effectiveness (Phase 2)Study completedNCT05275023
What this trial is testing
An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B Participants
Who this might be right for
Hepatitis B, Chronic
Janssen Research & Development, LLC 37